Vascarta commences a Phase I clinical study of VAS101 in osteoarthritis
Hand-out
Press Releases
Vascarta Inc  
March 18, 2025

Vascarta commences a Phase I clinical study of VAS101 in osteoarthritis

SUMMIT, N.J. , March 18, 2025 /PRNewswire/ -- A 60-patient, randomized, double-blind, placebo-controlled phase I clinical study of VAS101 (topical curcumin gel) in osteoarthritis (OA) is underway. The study is

avatar profile Olean Times Herald

Olean Times Herald


Local & Social